These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 19450719

  • 1. Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.
    Gradman AH.
    Am Heart J; 2009 Jun; 157(6 Suppl):S1-6. PubMed ID: 19450719
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
    Papademetriou V.
    Am Heart J; 2009 Jun; 157(6 Suppl):S24-30. PubMed ID: 19450721
    [Abstract] [Full Text] [Related]

  • 3. [The renin-angiotensin system].
    Hilgers KF.
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract] [Full Text] [Related]

  • 4. ONTARGET still OFF-TARGET?
    Lambers Heerspink HJ, de Zeeuw D.
    Circulation; 2011 Mar 15; 123(10):1049-51. PubMed ID: 21357820
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system.
    Segal A.
    N Engl J Med; 2004 Dec 02; 351(23):2450-1; author reply 2450-1. PubMed ID: 15575066
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G, Schulz R.
    Dtsch Med Wochenschr; 2006 Apr 13; 131(15):817-20. PubMed ID: 16607602
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin and its inhibition: a nephrologist point of view.
    Kalra V, Agarwal SK, Wani M.
    J Assoc Physicians India; 2002 Oct 13; 50():1270-80. PubMed ID: 12568213
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH, Papademetriou V.
    Am Heart J; 2009 Jun 13; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [Abstract] [Full Text] [Related]

  • 16. Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!
    Waeber B.
    J Renin Angiotensin Aldosterone Syst; 2012 Mar 13; 13(1):216. PubMed ID: 22389390
    [No Abstract] [Full Text] [Related]

  • 17. More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).
    Lip GY, Beevers DG.
    J Hum Hypertens; 2003 Nov 13; 17(11):747-50. PubMed ID: 14578913
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
    Palmer BF.
    Nephrol Dial Transplant; 2003 Oct 13; 18(10):1973-5. PubMed ID: 13679467
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.